Tianle Hu

Executive Director of Biostatistics

Role: Executive Director of Biostatistics at Eisai US
Location: Boston, MA, US
LinkedIn followers: 500 followers

About Tianle Hu

I am a biostatistics leader specializing in oncology, neuroscience, and rare diseases, with a career dedicated to advancing innovative therapies through early-stage clinical development. Currently, I serve as Head of Oncology Biostatistics at Eisai Inc, driving statistical strategy for experimental cancer therapies.Previously, I led the gene therapy biostatistics program at Sarepta Therapeutics for Duchenne Muscular Dystrophy, building on my earlier impact at Eli Lilly, where I contributed to Emgality’s global approvals and advanced statistical innovation in oncology.My expertise spans clinical trial design, survival analysis, and cross-functional collaboration, with a consistent focus on translating data into decisions that bring meaningful treatments to patients.

Experience

Executive Director of Biostatistics
Eisai US
Sep 2022 — Present · Boston, MA, US

Education

University of Michigan
Doctor of Philosophy (PhD), Biostatistics
2005 — 2011

Skills

Sas Programming
Clinical Research
Clinical Study Design
R
Drug Development
Pharmaceutical Industry
Survival Analysis
Phase I and Ii Clinical Trials
Clinical Trials
Biostatistics
Clinical Development
Statistical Modeling
Oncology

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@eisai.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Eisai US

Pharmaceutical Manufacturing · 2.7K employees · Founded 1995 · Nutley, New Jersey, United States

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US. Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

eisai.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.